Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blann

Showing results (401-410 of 420) with videos related to

Pageof 42
Sort By:
European Journal of Gynaecological Oncology|July 30, 2011
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS R Muthuramalingam, J P Braybrooke, A D Blann, et al.
Atherosclerosis|September 27, 2019
Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS studyKatarina D Kovacevic, Florian J Mayer, Bernd Jilma, et al.
BMC Bioinformatics|November 23, 2006
Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonistsLei Guo, Hong Fang, Jim Collins, et al.
The Journal of Rheumatology|September 11, 2003
Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosusJoel Constans, Remy Dupuy, Andrew D Blann, et al.
International Journal of Cardiology|October 30, 2012
Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?Yutao Guo, Ron Pisters, Stavros Apostolakis, et al.
Cell Biology and Toxicology|May 16, 2000
Increased expression of hepatic DNA methyltransferase in smokersG J Hammons, Y Yan, N G Lopatina, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) studyMartin J Landray, David C Wheeler, Gregory Y H Lip, et al.
Atherosclerosis|October 28, 2008
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT studyClaudio Ceconi, Kim M Fox, William J Remme, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillationD Kaireviciute, G Y H Lip, B Balakrishnan, et al.
Thrombosis and Haemostasis|May 12, 2010
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patientsDiana Kaireviciute, Andrew D Blann, Balu Balakrishnan, et al.
Pageof 42

Showing results (401-410 of 420) with videos related to

Sort By:
Pageof 42
European Journal of Gynaecological Oncology|July 30, 2011
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS R Muthuramalingam, J P Braybrooke, A D Blann, et al.
Atherosclerosis|September 27, 2019
Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS studyKatarina D Kovacevic, Florian J Mayer, Bernd Jilma, et al.
BMC Bioinformatics|November 23, 2006
Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonistsLei Guo, Hong Fang, Jim Collins, et al.
The Journal of Rheumatology|September 11, 2003
Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosusJoel Constans, Remy Dupuy, Andrew D Blann, et al.
International Journal of Cardiology|October 30, 2012
Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?Yutao Guo, Ron Pisters, Stavros Apostolakis, et al.
Cell Biology and Toxicology|May 16, 2000
Increased expression of hepatic DNA methyltransferase in smokersG J Hammons, Y Yan, N G Lopatina, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) studyMartin J Landray, David C Wheeler, Gregory Y H Lip, et al.
Atherosclerosis|October 28, 2008
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT studyClaudio Ceconi, Kim M Fox, William J Remme, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillationD Kaireviciute, G Y H Lip, B Balakrishnan, et al.
Thrombosis and Haemostasis|May 12, 2010
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patientsDiana Kaireviciute, Andrew D Blann, Balu Balakrishnan, et al.
Pageof 42